Does PACRITINIB Cause Product dose omission issue? 279 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 279 reports of Product dose omission issue have been filed in association with PACRITINIB (Vonjo). This represents 10.9% of all adverse event reports for PACRITINIB.
279
Reports of Product dose omission issue with PACRITINIB
10.9%
of all PACRITINIB reports
6
Deaths
60
Hospitalizations
How Dangerous Is Product dose omission issue From PACRITINIB?
Of the 279 reports, 6 (2.2%) resulted in death, 60 (21.5%) required hospitalization.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PACRITINIB. However, 279 reports have been filed with the FAERS database.
What Other Side Effects Does PACRITINIB Cause?
Diarrhoea (536)
Off label use (459)
Fatigue (320)
Death (261)
Nausea (246)
Platelet count decreased (237)
Haemoglobin decreased (171)
Asthenia (119)
Drug ineffective (98)
Dizziness (96)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which PACRITINIB Alternatives Have Lower Product dose omission issue Risk?
PACRITINIB vs PALBOCICLIB
PACRITINIB vs PALIPERIDONE
PACRITINIB vs PALIVIZUMAB
PACRITINIB vs PALONOSETRON
PACRITINIB vs PAMIDRONATE